Back to 
ABN AMRO Bank N.V.
ABN AMRO Bank N.V.
REGN
Showing 8 of 13 quarters
Position history for ABN AMRO Bank N.V.'s holdings in Regeneron Pharmaceuticals, Inc.
Yes. ABN AMRO Bank holds 678 shares of REGN (Regeneron Pharmaceuticals), worth $421,934, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. ABN AMRO Bank has held REGN since Q2 2023, across 13 quarterly 13F filings.
Current Value
$421,934
Current Shares
678
Total Value Change
-$222.5M
Total Shares Change
-212,944
Quarter-by-Quarter History
Other major holders of REGN: FMR LLC, Vanguard Group Inc.